Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus Proposal.

KIT mutations canine mast cell neoplasm classification grading staging targeted therapy treatment algorithms

Journal

Frontiers in veterinary science
ISSN: 2297-1769
Titre abrégé: Front Vet Sci
Pays: Switzerland
ID NLM: 101666658

Informations de publication

Date de publication:
2021
Historique:
received: 09 08 2021
accepted: 12 11 2021
entrez: 27 12 2021
pubmed: 28 12 2021
medline: 28 12 2021
Statut: epublish

Résumé

Mast cell neoplasms are one of the most frequently diagnosed malignancies in dogs. The clinical picture, course, and prognosis vary substantially among patients, depending on the anatomic site, grade and stage of the disease. The most frequently involved organ is the skin, followed by hematopoietic organs (lymph nodes, spleen, liver, and bone marrow) and mucosal sites of the oral cavity and the gastrointestinal tract. In cutaneous mast cell tumors, several grading and staging systems have been introduced. However, no comprehensive classification and no widely accepted diagnostic criteria have been proposed to date. To address these open issues and points we organized a Working Conference on canine mast cell neoplasms in Vienna in 2019. The outcomes of this meeting are summarized in this article. The proposed classification includes cutaneous mast cell tumors and their sub-variants defined by grading- and staging results, mucosal mast cell tumors, extracutaneous/extramucosal mast cell tumors without skin involvement, and mast cell leukemia (MCL). For each of these entities, diagnostic criteria are proposed. Moreover, we have refined grading and staging criteria for mast cell neoplasms in dogs based on consensus discussion. The criteria and classification proposed in this article should greatly facilitate diagnostic evaluation and prognostication in dogs with mast cell neoplasms and should thereby support management of these patients in daily practice and the conduct of clinical trials.

Identifiants

pubmed: 34957277
doi: 10.3389/fvets.2021.755258
pmc: PMC8702826
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

755258

Informations de copyright

Copyright © 2021 Willmann, Yuzbasiyan-Gurkan, Marconato, Dacasto, Hadzijusufovic, Hermine, Sadovnik, Gamperl, Schneeweiss-Gleixner, Gleixner, Böhm, Peter, Eisenwort, Moriggl, Li, Jawhar, Sotlar, Jensen-Jarolim, Sexl, Horny, Galli, Arock, Vail, Kiupel and Valent.

Déclaration de conflit d'intérêts

PV received research grants from Celgene, Novartis, Pfizer, and Incyte. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer BR declared a shared affiliation, though no other collaboration, with several of the authors MW, RM, and VS, to the handling editor.

Références

Zentralbl Veterinarmed A. 1967 Apr;14(3):272-81
pubmed: 4967309
Vet Comp Oncol. 2018 Dec;16(4):505-510
pubmed: 29893066
Vet Pathol. 2002 Sep;39(5):557-64
pubmed: 12243465
Vet Clin North Am Small Anim Pract. 2019 Sep;49(5):793-807
pubmed: 31147188
J Vet Intern Med. 2018 Jan;32(1):394-405
pubmed: 29194765
Vet Clin North Am Small Anim Pract. 2012 Jul;42(4):693-706, vi
pubmed: 22720809
Vet Comp Oncol. 2017 Mar;15(1):36-45
pubmed: 25643820
J Am Vet Med Assoc. 2013 May 15;242(10):1392-7
pubmed: 23634684
Vet Comp Oncol. 2007 Mar;5(1):31-7
pubmed: 19754799
J Am Vet Med Assoc. 1999 Dec 1;215(11):1629-34
pubmed: 14567425
Vet Pathol. 2002 Sep;39(5):529-35
pubmed: 12243462
J Am Vet Med Assoc. 2000 Jan 15;216(2):222-6
pubmed: 10649758
Vet Pathol. 2011 Jan;48(1):169-81
pubmed: 21160022
Allergy. 2012 Jul;67(7):858-68
pubmed: 22583069
J Vet Intern Med. 2006 Jul-Aug;20(4):933-40
pubmed: 16955819
Vet Pathol. 1984 Sep;21(5):469-74
pubmed: 6435301
Leuk Res. 2001 Jul;25(7):603-25
pubmed: 11377686
Vet Pathol. 2004 Jul;41(4):371-7
pubmed: 15232137
Vet Comp Oncol. 2014 Mar;12(1):58-66
pubmed: 22577893
Vet Comp Oncol. 2018 Dec;16(4):580-589
pubmed: 30047226
Vet Comp Oncol. 2019 Dec;17(4):451-455
pubmed: 31264352
J Am Anim Hosp Assoc. 2002 Jan-Feb;38(1):67-70
pubmed: 11804318
Vet Comp Oncol. 2018 Mar;16(1):E194-E201
pubmed: 29239110
PLoS One. 2014 Apr 18;9(4):e95481
pubmed: 24748173
Vet Comp Oncol. 2009 Jun;7(2):130-8
pubmed: 19453367
Vet J. 2013 Jun;196(3):492-8
pubmed: 23384436
PLoS One. 2018 Dec 19;13(12):e0208026
pubmed: 30566430
Vet Comp Oncol. 2018 Mar;16(1):28-36
pubmed: 28233400
Vet Comp Oncol. 2016 Sep;14(3):245-51
pubmed: 24717019
J Vet Intern Med. 2014 Mar-Apr;28(2):547-53
pubmed: 24372836
Clin Cancer Res. 2009 Jun 1;15(11):3856-65
pubmed: 19470739
J Comp Pathol. 2007 May;136(4):231-9
pubmed: 17399734
Vet J. 2016 Sep;215:43-54
pubmed: 27372911
J Small Anim Pract. 1980 Apr;21(4):207-12
pubmed: 6768929
J Vet Diagn Invest. 2005 Nov;17(6):561-4
pubmed: 16475514
BMC Cancer. 2014 Feb 11;14:84
pubmed: 24517413
Can Vet J. 2017 Sep;58(9):931-935
pubmed: 28878416
Acta Vet Scand. 2018 Nov 3;60(1):70
pubmed: 30390687
Vet J. 2018 Dec;242:15-23
pubmed: 30503539
Vet Comp Oncol. 2016 Mar;14(1):101-11
pubmed: 24215587
Vet Comp Oncol. 2015 Mar;13(1):70-6
pubmed: 23451809
Vet Pathol. 1982 Nov;19(6):608-15
pubmed: 6815869
Vet Pathol. 2012 Nov;49(6):988-97
pubmed: 22446323
Vet Pathol. 2018 Mar;55(2):212-223
pubmed: 29338615
J Vet Intern Med. 2008 Nov-Dec;22(6):1301-9
pubmed: 18823406
Aust Vet J. 2018 May;96(5):184-187
pubmed: 29691857
J Vet Intern Med. 2008 Jul-Aug;22(4):1001-7
pubmed: 18564225
Vet Comp Oncol. 2019 Mar;17(1):1-10
pubmed: 30136349
Can Vet J. 2017 Jun;58(6):591-596
pubmed: 28588331
Vet Comp Oncol. 2018 Dec;16(4):535-543
pubmed: 29989314
J Comp Pathol. 2014 Nov;151(4):329-38
pubmed: 25172053
Vet Pathol. 1978 Jan;15(1):64-7
pubmed: 415404
Vet Q. 2004 Dec;26(4):156-69
pubmed: 15663212
J Am Anim Hosp Assoc. 2004 Jan-Feb;40(1):82-5
pubmed: 14736910
Vet Pathol. 2011 Jan;48(1):147-55
pubmed: 21062911
J Vet Intern Med. 1987 Apr-Jun;1(2):75-80
pubmed: 3506091
Vet Comp Oncol. 2012 Sep;10(3):e1-e29
pubmed: 22882486
J Vet Intern Med. 2009 Sep-Oct;23(5):1051-7
pubmed: 19656285
Vet Pathol. 2011 Jan;48(1):156-68
pubmed: 21078881
J Small Anim Pract. 1973 Jan;14(1):27-41
pubmed: 4199921
J Am Vet Med Assoc. 2014 Feb 1;244(3):346-51
pubmed: 24432967
Can Vet J. 2017 Aug;58(8):851-854
pubmed: 28761193
J Vet Diagn Invest. 2004 Nov;16(6):554-61
pubmed: 15586571
J Am Vet Med Assoc. 1999 Aug 1;215(3):355-7
pubmed: 10434973
J Vet Med Sci. 2009 Feb;71(2):229-32
pubmed: 19262039
Animals (Basel). 2021 Aug 11;11(8):
pubmed: 34438830
Vet Comp Oncol. 2021 Sep;19(3):451-462
pubmed: 32840038
Vet Comp Oncol. 2018 Mar;16(1):55-68
pubmed: 28397975
J Vet Intern Med. 2006 Jan-Feb;20(1):151-8
pubmed: 16496935
Vet Surg. 2021 Jan;50(1):133-141
pubmed: 33169849
Leukemia. 2016 Jan;30(1):136-43
pubmed: 26464169
J Vet Med Sci. 2000 Feb;62(2):187-90
pubmed: 10720189
J Am Vet Med Assoc. 2015 Apr 1;246(7):765-9
pubmed: 25794126
Vet Comp Oncol. 2017 Dec;15(4):1240-1256
pubmed: 27507155
Exp Hematol. 1999 Apr;27(4):689-97
pubmed: 10210327
J Comp Pathol. 2013 Jul;149(1):19-29
pubmed: 23276382
BMC Vet Res. 2019 Jun 17;15(1):204
pubmed: 31208404
J Am Vet Med Assoc. 2004 Jan 1;224(1):79-82
pubmed: 14710881
Vet Pathol. 2007 May;44(3):298-308
pubmed: 17491070
Neoplasia. 2006 Feb;8(2):104-11
pubmed: 16611403
J Am Vet Med Assoc. 1974 Aug 15;165(4):346-9
pubmed: 4211931
Vet Comp Oncol. 2020 Dec;18(4):818-824
pubmed: 32216019
Mol Cancer Res. 2008 Jul;6(7):1137-45
pubmed: 18644978
Cancer Res. 2017 Mar 15;77(6):1261-1270
pubmed: 28254862
J Am Vet Med Assoc. 2010 Oct 15;237(8):936-42
pubmed: 20946081
Vet Comp Oncol. 2014 Sep;12(3):215-26
pubmed: 22958227
J Vet Intern Med. 2006 Jul-Aug;20(4):955-61
pubmed: 16955822
Vet Rec. 2006 Mar 4;158(9):287-91
pubmed: 16517820
Vet Immunol Immunopathol. 2013 Aug 15;154(3-4):153-9
pubmed: 23791075
Vet Pathol. 2016 Nov;53(6):1117-1123
pubmed: 27034386
Vet Clin North Am Small Anim Pract. 2003 May;33(3):473-89, v
pubmed: 12852232
Vet Pathol. 2013 Jan;50(1):110-21
pubmed: 22673539
J Vet Diagn Invest. 2005 May;17(3):245-8
pubmed: 15945380
J Comp Pathol. 2000 Nov;123(4):306-10
pubmed: 11042002
Vet Clin North Am Small Anim Pract. 2019 Sep;49(5):819-836
pubmed: 31178200
Vet Comp Oncol. 2020 Dec;18(4):634-644
pubmed: 32134562

Auteurs

Michael Willmann (M)

Department/Hospital for Companion Animals and Horses, Clinic for Internal Medicine and Infectious Diseases, University of Veterinary Medicine Vienna, Vienna, Austria.
Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.

Vilma Yuzbasiyan-Gurkan (V)

Comparative Medicine and Integrative Biology Program, College of Veterinary Medicine, Michigan State University, East Lansing, MI, United States.

Laura Marconato (L)

Department of Veterinary Medical Science, University of Bologna, Ozzano dell'Emilia, Italy.

Mauro Dacasto (M)

Department of Comparative Biomedicine and Food Science, University of Padua, Padua, Italy.

Emir Hadzijusufovic (E)

Department/Hospital for Companion Animals and Horses, Clinic for Internal Medicine and Infectious Diseases, University of Veterinary Medicine Vienna, Vienna, Austria.
Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Olivier Hermine (O)

Department of Hematology, Imagine Institute Université de Paris, INSERM U1163, CEREMAST, Necker Hospital, Paris, France.

Irina Sadovnik (I)

Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Susanne Gamperl (S)

Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Mathias Schneeweiss-Gleixner (M)

Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Karoline V Gleixner (KV)

Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Thomas Böhm (T)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Barbara Peter (B)

Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Gregor Eisenwort (G)

Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Richard Moriggl (R)

Institute of Animal Breeding and Genetics, University of Veterinary Medicine, Vienna, Austria.

Zhixiong Li (Z)

Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hanover Medical School, Hanover, Germany.

Mohamad Jawhar (M)

Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.

Karl Sotlar (K)

Institute of Pathology, Paracelsus Medical University of Salzburg, Salzburg, Austria.

Erika Jensen-Jarolim (E)

Center of Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
The Interuniversity Messerli Research Institute, University of Veterinary Medicine Vienna, Medical University Vienna, University of Vienna, Vienna, Austria.

Veronika Sexl (V)

Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria.

Hans-Peter Horny (HP)

Institute of Pathology, Paracelsus Medical University of Salzburg, Salzburg, Austria.
Institute of Pathology, Ludwig-Maximilians University, Munich, Germany.

Stephen J Galli (SJ)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States.
Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, United States.

Michel Arock (M)

Laboratory of Hematology, Pitié-Salpêtrière Hospital, Paris, France.

David M Vail (DM)

Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, United States.
Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, United States.

Matti Kiupel (M)

Pathobiology and Diagnostic Investigation, College of Veterinary Medicine, Michigan State University, East Lansing, MI, United States.

Peter Valent (P)

Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Classifications MeSH